Scott Metcalfe
About
In The Last Decade
Scott Metcalfe
26 papers receiving 353 citations
Peers
Comparison fields: 5 of 85
- General Health Professions 92
- Applied Microbiology and Biotechnology 91
- Economics and Econometrics 72
- Geriatrics and Gerontology 48
- Pediatrics, Perinatology and Child Health 44
Countries citing papers authored by Scott Metcalfe
This map shows the geographic impact of Scott Metcalfe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott Metcalfe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott Metcalfe more than expected).
Fields of papers citing papers by Scott Metcalfe
This network shows the impact of papers produced by Scott Metcalfe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott Metcalfe. The network helps show where Scott Metcalfe may publish in the future.
Co-authorship network of co-authors of Scott Metcalfe
This figure shows the co-authorship network connecting the top 25 collaborators of Scott Metcalfe. A scholar is included among the top collaborators of Scott Metcalfe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott Metcalfe. Scott Metcalfe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Effectiveness of a preschool asthma education programme, compared to usual care, on the frequency of acute asthma events: a community-based cluster randomised trial. | 1 |
| 2 | 0 | |
| 3 | Te Wero tonu-the challenge continues: Māori access to medicines 2006/07-2012/13 update. | 31 |
| 4 | Dispensing patterns for antidiabetic agents in New Zealand: are the guidelines being followed? | 4 |
| 5 | A kick in the butt: time to address tobacco waste in New Zealand. | 2 |
| 6 | 98 | |
| 7 | 9 | |
| 8 | Health and equity impacts of climate change in Aotearoa-New Zealand, and health gains from climate action. | 17 |
| 9 | 16 | |
| 10 | Assessing the value for money of pharmaceuticals in New Zealand--PHARMAC's approach to cost-utility analysis. | 7 |
| 11 | Variation in the use of medicines by ethnicity during 2006/07 in New Zealand: a preliminary analysis. | 27 |
| 12 | Terminations of pregnancy associated with isotretinoin use in New Zealand. | 3 |
| 13 | Do pharmaceutical score cards give us the answers we seek? | 7 |
| 14 | 5 | |
| 15 | PHARMAC funding of 9-week concurrent trastuzumab (Herceptin) for HER2-positive early breast cancer. | 12 |
| 16 | Response from PHARMAC: difficult choices. | 9 |
| 17 | PHARMAC measures savings elsewhere to the health sector. | 14 |
| 18 | Insulin lispro improves postprandial glucose control in patients with diabetes mellitus. | 8 |
| 19 | 14 | |
| 20 | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.